Medicxi Growth I LP's Form 4 filing
Centessa Pharmaceuticals plc (CNTA) · filed Dec 2, 2021
- Accession no.
- 0000899243-21-046591
- Filed
- Dec 2, 2021, 5:10 PM ET
- Trade date
- Nov 30-Dec 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $1.19M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Medicxi Growth I LPCIK 0001690310 | 10% Owner |
| Medicxi Growth Co-Invest I LPCIK 0001715578 | 10% Owner |
| Medicxi Ventures Management (Jersey) LtdCIK 0001715579 | 10% Owner |
| Medicxi Growth I GP LtdCIK 0001715600 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | Ordinary Shares | PPurchaseAcquired | +35,992 | $11.62 | +$418,227.04 | 3,844,535 | Indirect | Duplicate filing |
| Nov 30, 2021 | Ordinary Shares | PPurchaseAcquired | +855 | $11.62 | +$9,935.1 | 91,331 | Indirect | Duplicate filing |
| Dec 1, 2021 | Ordinary Shares | PPurchaseAcquired | +58,905 | $12.62 | +$743,381.1 | 3,903,440 | Indirect | Duplicate filing |
| Dec 1, 2021 | Ordinary Shares | PPurchaseAcquired | +1,399 | $12.62 | +$17,655.38 | 92,730 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Medicxi Ventures (UK) LLP and Medicxi Ventures (Jersey) Limited act as sub-advisers to Index Ventures Life VI (Jersey) Limited, which acts as the adviser to Index Ventures Life VI (Jersey) LP, and as such, Index Ventures Life VI and Yucca (Jersey) SLP, each of which hold Ordinary Shares as of the date hereof, and the Medicxi Funds may be deemed to be members of a "group" as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended.